Zhao Yang, Zhang Yong, Wang Mingchao, Meng Bo, Ying Wantao, Qian Xiaohong
College of Life Science and Bioengineering, Beijing University of Technology, Beijing, 100124, China.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences(Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.
Se Pu. 2018 Dec 8;36(12):1197-1205. doi: 10.3724/SP.J.1123.2018.08017.
Though plant lectins have been widely used for the enrichment of glycoproteins/glycopeptides, mammalian lectins have rarely been explored for this purpose. Using the conserved sequence of the carbohydrate recognition domain (CRD) of the human galectin-3 protein, we engineered the following two novel human galectins:Gal3C (containing one CRD) and Tetra-Gal3C (containing four tandem CRDs). Moreover, we designed a galectin affinity column that could be used for glycoprotein/glycopeptide enrichment, by taking advantage of the ability of these recombinant galectins to become immobilized onto streptavidin agarose beads. SDS-PAGE, western blotting, and mass spectrometry were used to characterize the biological features and glycoprotein/glycopeptide enrichment abilities of both these recombinant galectins. Our results showed that both Gal3C and Tetra-Gal3C predominantly enrich glycoproteins/glycopeptides and that this enrichment process has a high specificity and sensitivity. Because Tetra-Gal3C contains three more CRD structural domains, it exhibited a better ability to achieve enrichment than Gal3C. Moreover, the immobilized Gal3C and Tetra-Gal3C were successfully used for the enrichment of glycoproteins from HepG2 cells, which indicated the selective glycoprotein/glycopeptide enrichment potential of recombinant galectins in complex samples.
尽管植物凝集素已被广泛用于糖蛋白/糖肽的富集,但哺乳动物凝集素在这方面却鲜有探索。利用人半乳糖凝集素-3蛋白碳水化合物识别结构域(CRD)的保守序列,我们构建了以下两种新型人半乳糖凝集素:Gal3C(含一个CRD)和四聚体-Gal3C(含四个串联CRD)。此外,我们利用这些重组半乳糖凝集素固定在链霉亲和素琼脂糖珠上的能力,设计了一种可用于糖蛋白/糖肽富集的半乳糖凝集素亲和柱。采用SDS-PAGE、蛋白质印迹和质谱对这两种重组半乳糖凝集素的生物学特性和糖蛋白/糖肽富集能力进行表征。我们的结果表明,Gal3C和四聚体-Gal3C都主要富集糖蛋白/糖肽,且这种富集过程具有高特异性和高灵敏度。由于四聚体-Gal3C多含三个CRD结构域,其富集能力比Gal3C更好。此外,固定化的Gal3C和四聚体-Gal3C成功用于从HepG2细胞中富集糖蛋白,这表明重组半乳糖凝集素在复杂样品中具有选择性糖蛋白/糖肽富集潜力。